Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:441-445
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 1995 American Heart Association, Inc.
Articles |
Patients With Early-Onset Peripheral Vascular Disease Have Increased Levels of Autoantibodies Against Oxidized LDL
From the Departments of Surgery (C.B., J.S.) and Medicine (R.W., U. de F., A.K.L.), Karolinska Hospital, Stockholm, Sweden.
Correspondence to Jesper Swedenborg, MD, Department of Surgery, Karolinska Hospital, S-171 76 Stockholm, Sweden.
Abstract Oxidative modification of LDL has been proposed as an early and crucial step in the development of atherosclerosis, and antibodies against such modified LDL are found in both healthy individuals and patients with atherosclerosis. In this study, 62 patients who were surgically treated for peripheral arterial occlusive disease below the age of 50 were investigated and compared with age- and sex-matched healthy individuals in a case-control study. Autoantibodies against oxidized LDL were measured with an enzyme-linked immunosorbent assay method. Risk factors such as smoking, hypertension, family history of premature cardiovascular events, and lipoprotein levels were also determined. The patients had significantly higher levels of autoantibodies against oxidized LDL; significantly higher levels of total cholesterol, LDL cholesterol, triglycerides, and apo A-I; and significantly lower levels of HDL cholesterol than did control subjects. In multivariate analyses autoantibodies against oxidized LDL discriminated better between patients and control subjects than did any of the different lipoprotein analyses. Among patients, the presence of hypertension and a family history of cardiovascular events were the only factors significantly associated with increased levels of autoantibodies against oxidized LDL.
Key Words: lipoproteins • oxidation • risk factors • premature atherosclerosis • antibodies
This article has been cited by other articles:
 |
|
 |
|
  P. C. Dimayuga, X. Zhao, J. Yano, and K.-Y. Chyu Changes in immune responses to oxidized LDL epitopes during aging in hypercholesterolemic apoE(-/-) mice Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1644 - R1650. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Shoenfeld, R. Gerli, A. Doria, E. Matsuura, M. M. Cerinic, N. Ronda, L. J. Jara, M. Abu-Shakra, P. L. Meroni, and Y. Sherer Accelerated Atherosclerosis in Autoimmune Rheumatic Diseases Circulation, November 22, 2005; 112(21): 3337 - 3347. [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Tinahones, J. M. Gomez-Zumaquero, L. Garrido-Sanchez, E. Garcia-Fuentes, G. Rojo-Martinez, I. Esteva, M. S. R. de Adana, F. Cardona, and F. Soriguer Influence of age and sex on levels of anti-oxidized LDL antibodies and anti-LDL immune complexes in the general population J. Lipid Res., March 1, 2005; 46(3): 452 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. K. Hansson Glimpse of the Secret Life of the Plaque Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2203 - 2204. [Full Text] [PDF]
|
|
|
|
|
|
Y. Shoenfeld, R. Wu, L. D. Dearing, and E. Matsuura Are Anti-Oxidized Low-Density Lipoprotein Antibodies Pathogenic or Protective? Circulation, October 26, 2004; 110(17): 2552 - 2558. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Stocker and J. F. Keaney Jr. Role of Oxidative Modifications in Atherosclerosis Physiol Rev, October 1, 2004; 84(4): 1381 - 1478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. P. Rossi, M. Cesari, R. De Toni, M. Zanchetta, G. Maiolino, L. Pedon, C. Ganzaroli, P. Maiolino, and A. C. Pessina Antibodies to Oxidized Low-Density Lipoproteins and Angiographically Assessed Coronary Artery Disease in White Patients Circulation, November 18, 2003; 108(20): 2467 - 2472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. N. Fredrikson, B. Hedblad, G. Berglund, R. Alm, M. Ares, B. Cercek, K.-Y. Chyu, P. K. Shah, and J. Nilsson Identification of Immune Responses Against Aldehyde-Modified Peptide Sequences in ApoB Associated With Cardiovascular Disease Arterioscler. Thromb. Vasc. Biol., May 1, 2003; 23(5): 872 - 878. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. N. Fredrikson, I. Soderberg, M. Lindholm, P. Dimayuga, K.-Y. Chyu, P. K. Shah, and J. Nilsson Inhibition of Atherosclerosis in ApoE-Null Mice by Immunization with ApoB-100 Peptide Sequences Arterioscler. Thromb. Vasc. Biol., May 1, 2003; 23(5): 879 - 884. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kobayashi, M. Kishi, T. Atsumi, M. L. Bertolaccini, H. Makino, N. Sakairi, I. Yamamoto, T. Yasuda, M. A. Khamashta, G. R. V. Hughes, et al. Circulating oxidized LDL forms complexes with {beta}2-glycoprotein I: implication as an atherogenic autoantigen J. Lipid Res., April 1, 2003; 44(4): 716 - 726. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Alexander Oxidized LDL Autoantibodies, Endothelial Dysfunction, and Transplant-Associated Arteriosclerosis Arterioscler. Thromb. Vasc. Biol., December 1, 2002; 22(12): 1950 - 1951. [Full Text] [PDF]
|
|
|
|
|
|
J. C. Fang, S. Kinlay, D. Behrendt, H. Hikita, J. L. Witztum, A. P. Selwyn, and P. Ganz Circulating Autoantibodies to Oxidized LDL Correlate With Impaired Coronary Endothelial Function After Cardiac Transplantation Arterioscler. Thromb. Vasc. Biol., December 1, 2002; 22(12): 2044 - 2048. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y Sherer and Y Shoenfeld Atherosclerosis Ann Rheum Dis, February 1, 2002; 61(2): 97 - 99. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. K. Hansson Immune Mechanisms in Atherosclerosis Arterioscler. Thromb. Vasc. Biol., December 1, 2001; 21(12): 1876 - 1890. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. MERTENS and P. HOLVOET Oxidized LDL and HDL: antagonists in atherothrombosis FASEB J, October 1, 2001; 15(12): 2073 - 2084. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Peters, C. Poole, and L. Arab Does Tea Affect Cardiovascular Disease? A Meta-Analysis Am. J. Epidemiol., September 15, 2001; 154(6): 495 - 503. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. de Geest and D. Collen Antibodies against oxidized LDL for non-invasive diagnosis of atherosclerotic vascular disease Eur. Heart J., September 1, 2001; 22(17): 1517 - 1518. [PDF]
|
|
|
|
|
|
C. Monaco, F. Crea, G. Niccoli, F. Summaria, D. Cianflone, R. Bordone, G. Bellomo, and A. Maseri Autoantibodies against oxidized low density lipoproteins in patients with stable angina, unstable angina or peripheral vascular disease; pathophysiological implications Eur. Heart J., September 1, 2001; 22(17): 1572 - 1577. [Abstract] [PDF]
|
|
|
|
 |
|
 P. Rubba, S. Panico, M. G. Bond, G. Covetti, E. Celentano, A. Iannuzzi, R. Galasso, M. A. Belisario, A. Pastinese, L. Sacchetti, et al. Site-Specific Atherosclerotic Plaques in the Carotid Arteries of Middle-Aged Women From Southern Italy: Associations With Traditional Risk Factors and Oxidation Markers Stroke, September 1, 2001; 32(9): 1953 - 1959. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Trevisan, R. Browne, M. Ram, P. Muti, J. Freudenheim, A. M. Carosella, and D. Armstrong Correlates of Markers of Oxidative Status in the General Population Am. J. Epidemiol., August 15, 2001; 154(4): 348 - 356. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Inoue, T. Uchida, H. Kamishirado, K. Takayanagi, and S. Morooka Antibody against oxidized low density lipoprotein may predict progression or regression of atherosclerotic coronary artery disease J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1871 - 1876. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Inoue, T. Uchida, H. Kamishirado, K. Takayanagi, T. Hayashi, and S. Morooka Clinical significance of antibody against oxidized low density lipoprotein in patients with atherosclerotic coronary artery disease J. Am. Coll. Cardiol., March 1, 2001; 37(3): 775 - 779. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I S Young and J V Woodside Antioxidants in health and disease J. Clin. Pathol., March 1, 2001; 54(3): 176 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hulthe, O. Wiklund, E. Hurt-Camejo, and G. Bondjers Antibodies to Oxidized LDL in Relation to Carotid Atherosclerosis, Cell Adhesion Molecules, and Phospholipase A2 Arterioscler. Thromb. Vasc. Biol., February 1, 2001; 21(2): 269 - 274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Pratico, R. K. Tangirala, S. Horkko, J. L. Witztum, W. Palinski, and G. A. FitzGerald Circulating autoantibodies to oxidized cardiolipin correlate with isoprostane F2{alpha}-VI levels and the extent of atherosclerosis in ApoE-deficient mice: modulation by vitamin E Blood, January 15, 2001; 97(2): 459 - 464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Tsimikas, W. Palinski, and J. L. Witztum Circulating Autoantibodies to Oxidized LDL Correlate With Arterial Accumulation and Depletion of Oxidized LDL in LDL Receptor-Deficient Mice Arterioscler. Thromb. Vasc. Biol., January 1, 2001; 21(1): 95 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hulthe, L. Bokemark, and B. Fagerberg Antibodies to Oxidized LDL in Relation to Intima-Media Thickness in Carotid and Femoral Arteries in 58-Year-Old Subjectively Clinically Healthy Men Arterioscler. Thromb. Vasc. Biol., January 1, 2001; 21(1): 101 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Wu, C. Lemne, U. de Faire, and J. Frostegard Antibodies to Lysophosphatidylcholine Are Decreased in Borderline Hypertension Hypertension, January 1, 2001; 37(1): 154 - 159. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Mustafa, S. Nityanand, L. Berglund, H. Lithell, and A. K. Lefvert Circulating Immune Complexes in 50-Year-Old Men as a Strong and Independent Risk Factor for Myocardial Infarction Circulation, November 21, 2000; 102(21): 2576 - 2581. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. G. de Oliveira, C. L. Rossi, M. G. de Oliveira, M. J.A. Saad, and L. A. Velloso Effect of vitamin E supplementation on antibody levels against malondialdehyde modified LDL in hyperlipidemic hamsters Cardiovasc Res, August 18, 2000; 47(3): 567 - 573. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J George, A Afek, B Gilburd, D Harats, and Y Shoenfeld Autoimmunity in atherosclerosis: lessons from experimental models Lupus, March 1, 2000; 9(3): 223 - 227. [Abstract] [PDF]
|
|
|
|
|
|
M. Fukumoto, T. Shoji, M. Emoto, T. Kawagishi, Y. Okuno, and Y. Nishizawa Antibodies Against Oxidized LDL and Carotid Artery Intima-Media Thickness in a Healthy Population Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 703 - 707. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Mansoor, C. Bergmark, S. J. Haswell, I. F. Savage, P. H. Evans, R. K. Berge, A. M. Svardal, and O. Kristensen Correlation between Plasma Total Homocysteine and Copper in Patients with Peripheral Vascular Disease Clin. Chem., March 1, 2000; 46(3): 385 - 391. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Deguchi, J. A. Fernandez, T. M. Hackeng, C. L. Banka, and J. H. Griffin Cardiolipin is a normal component of human plasma lipoproteins PNAS, February 15, 2000; 97(4): 1743 - 1748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. T. Erkkila, O. Narvanen, S. Lehto, M. I. J. Uusitupa, and S. Yla-Herttuala Autoantibodies Against Oxidized Low-Density Lipoprotein and Cardiolipin in Patients With Coronary Heart Disease Arterioscler. Thromb. Vasc. Biol., January 1, 2000; 20(1): 204 - 209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Ahmed, J. Trifunovic, B. Stegmayr, G. Hallmans, and A. K. Lefvert Autoantibodies Against Oxidatively Modified LDL Do Not Constitute a Risk Factor for Stroke : A Nested Case-Control Study Stroke, December 1, 1999; 30(12): 2541 - 2546. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Wu, U. de Faire, C. Lemne, J. L. Witztum, and J. Frostegard Autoantibodies to OxLDL Are Decreased in Individuals With Borderline Hypertension Hypertension, January 1, 1999; 33(1): 53 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Freigang, S. Horkko, E. Miller, J. L. Witztum, and W. Palinski Immunization of LDL Receptor–Deficient Mice With Homologous Malondialdehyde-Modified and Native LDL Reduces Progression of Atherosclerosis by Mechanisms Other Than Induction of High Titers of Antibodies to Oxidative Neoepitopes Arterioscler. Thromb. Vasc. Biol., December 1, 1998; 18(12): 1972 - 1982. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Frostegard, R. Wu, C. Gillis-Haegerstrand, C. Lemne, and U. de Faire Antibodies to Endothelial Cells in Borderline Hypertension Circulation, September 15, 1998; 98(11): 1092 - 1098. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hulthe, J. Wikstrand, A. Lidell, I. Wendelhag, G. K. Hansson, and O. Wiklund Antibody Titers Against Oxidized LDL Are Not Elevated in Patients With Familial Hypercholesterolemia Arterioscler. Thromb. Vasc. Biol., August 1, 1998; 18(8): 1203 - 1211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Wu, Y. H. Huang, L. S. Elinder, and J. Frostegard Lysophosphatidylcholine Is Involved in the Antigenicity of Oxidized LDL Arterioscler. Thromb. Vasc. Biol., April 1, 1998; 18(4): 626 - 630. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Wu, S. Nityanand, L. Berglund, H. Lithell, G. Holm, and A. K. Lefvert Antibodies Against Cardiolipin and Oxidatively Modified LDL in 50-Year-Old Men Predict Myocardial Infarction Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 3159 - 3163. [Abstract] [Full Text]
|
|
|
|
|
|
C. Iribarren, A. R. Folsom, D. R. Jacobs Jr, M. D. Gross, J. D. Belcher, and J. H. Eckfeldt Association of Serum Vitamin Levels, LDL Susceptibility to Oxidation, and Autoantibodies Against MDA-LDL With Carotid Atherosclerosis: A Case-Control Study Arterioscler. Thromb. Vasc. Biol., June 1, 1997; 17(6): 1171 - 1177. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. D. Watson, N. Leitinger, M. Navab, K. F. Faull, S. Horkko, J. L. Witztum, W. Palinski, D. Schwenke, R. G. Salomon, W. Sha, et al. Structural Identification by Mass Spectrometry of Oxidized Phospholipids in Minimally Oxidized Low Density Lipoprotein That Induce Monocyte/Endothelial Interactions and Evidence for Their Presence in Vivo J. Biol. Chem., May 23, 1997; 272(21): 13597 - 13607. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Seccia, E. Albano, E. Maggi, and G. Bellomo Circulating Autoantibodies Recognizing Peroxidase-Oxidized Low Density Lipoprotein: Evidence for New Antigenic Epitopes Formed In Vivo Independently From Lipid Peroxidation Arterioscler. Thromb. Vasc. Biol., January 1, 1997; 17(1): 134 - 140. [Abstract] [Full Text]
|
|
|
|
|
|
M. Mironova, G. Virella, and M. F. Lopes-Virella Isolation and Characterization of Human Antioxidized LDL Autoantibodies Arterioscler. Thromb. Vasc. Biol., February 1, 1996; 16(2): 222 - 229. [Abstract] [Full Text]
|
|
|
|
|
|
W. Palinski, R. K. Tangirala, E. Miller, S. G. Young, and J. L. Witztum Increased Autoantibody Titers Against Epitopes of Oxidized LDL in LDL Receptor–Deficient Mice With Increased Atherosclerosis Arterioscler. Thromb. Vasc. Biol., October 1, 1995; 15(10): 1569 - 1576. [Abstract] [Full Text]
|
|